1. Home
  2. VRCA vs BYFC Comparison

VRCA vs BYFC Comparison

Compare VRCA & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$3.55

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Logo Broadway Financial Corporation

BYFC

Broadway Financial Corporation

N/A

Current Price

$11.66

Market Cap

104.4M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VRCA
BYFC
Founded
2013
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.0M
104.4M
IPO Year
2018
2013

Fundamental Metrics

Financial Performance
Metric
VRCA
BYFC
Price
$3.55
$11.66
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
★ $13.83
N/A
AVG Volume (30 Days)
★ 59.0K
2.1K
Earning Date
11-12-2026
07-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ 0.07
Revenue
★ $35,577,000.00
$184,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$60.79
N/A
P/E Ratio
★ N/A
$165.71
Revenue Growth
★ 370.22
18.71
52 Week Low
$3.08
$5.51
52 Week High
$9.82
$12.35

Technical Indicators

Market Signals
Indicator
VRCA
BYFC
Relative Strength Index (RSI) 47.56 63.80
Support Level $3.30 $11.76
Resistance Level $5.94 $12.27
Average True Range (ATR) 0.30 0.14
MACD 0.04 0.06
Stochastic Oscillator 45.87 100.00

Price Performance

Historical Comparison
VRCA
BYFC

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank offers a variety of commercial real estate loan products, services, and depository accounts that support investments in affordable housing, small businesses, and nonprofit community facilities located within low-to-moderate income neighborhoods.

Share on Social Networks: